Latest News for PHCUF
OSLO, Norway, April 13, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today announced that the U.S. Food and Drug Administration (FDA) has communicated to Photocure that it plans to issue a proposed order to reclassify diagnostic endoscopic light source systems (FDA Product Code OAY) under its own initiative per Section 513(f)(3) of the Federal Food, Drug, and Cosmetic Act. This information was shared with Photocure…
Photocure ASA (PHCUF) Q4 2025 Earnings Call Transcript
OSLO, Norway, Feb. 18, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 135.1 million in the fourth quarter of 2025 (Q4 2024: NOK 128.6 million), and a commercial EBITDA of NOK 8.4 million (Q4 2024: NOK 3.9 million) for the company. In 2026, Photocure expects product revenue growth in the range of 7% to 11% on a constant currency basis and continued operating leverage…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PHCUF.
Senate Trading
No Senate trades found for PHCUF.
U.S. House Trading
No House trades found for PHCUF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.